Indications for FLUARIX QUADRIVALENT:
Adults and Children:
<6mos: not established. Each dose is 0.5mL by IM inj once in the anterolateral thigh (6–11mos) or the deltoid (≥12mos). 6mos–8yrs (previously unvaccinated): 2 doses, give at least 4 weeks apart; (vaccinated in a previous season): 1 or 2 doses (depending on vaccination history as per annual ACIP recommendation); if 2 doses, give at least 4 weeks apart. ≥9yrs: 1 dose.
FLUARIX QUADRIVALENT Contraindications:
Allergy to egg protein or following a previous flu vaccine administration.
FLUARIX QUADRIVALENT Warnings/Precautions:
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Bleeding disorders. Immunosuppressed. Risk of sycope with injectable vaccines. Have epinephrine inj (1:1000) available. Pregnancy. Nursing mothers.
FLUARIX QUADRIVALENT Interactions:
Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids): may result in suboptimal response.
Local reactions (eg, redness, swelling, pain), muscle aches, fatigue, headache, arthralgias, GI symptoms, shivering, fever; children: irritability, loss of appetite, drowsiness.
Generic Drug Availability:
Single-dose prefilled Tip-Lok syringes (0.5mL)—10